Jakafi (ruxolitinib) - Incyte
Vonjo (pacritinib) - SOBI
Xpovio (selinexor) - Karyopharm
Ojjaara (momelotinib) - GSK
http://clinicaltrials.gov/ct2/show/NCT05980806
 
Feb 13, 2026
 
Next